List of Tables
Summary Table: Global Market for Pharmaceutical Drugs, by Region, Through 2029
Table 1: Global Health Expenditures, by Country, 2022
Table 2: Global Incidence of All Cancers, by WHO Region, 2022-2050
Table 3: Pharmaceutical Drug Patents Granted, by Leading Applicant, 2023
Table 4: Pharmaceutical Drug Patents Granted, by Assignee Country/Region, January 2023-January 2025
Table 5: ESG Rankings for Pharmaceutical Companies
Table 6: Global Market Shares of Pharmaceutical Drugs, by Company, 2023
Table 7: Best-Selling Pharmaceuticals, 2023
Table 8: Total Revenue, Pharmaceutical Revenue, R&D Expenditure and Percentage of R&D in Revenue, by Drug Manufacturer, 2023
Table 9: Abbreviations Used in this Report
Table 10: Information Sources Used for this Report
Table 11: Abbott: Company Snapshot
Table 12: Abbott: Financial Performance, FY 2022 and 2023
Table 13: Abbott: Product Portfolio
Table 14: AbbVie Inc.: Company Snapshot
Table 15: AbbVie Inc.: Financial Performance, FY 2022 and 2023
Table 16: AbbVie Inc.: Product Portfolio
Table 17: AbbVie Inc.: News/Key Developments, 2023-2025
Table 18: Alnylam Pharmaceuticals Inc.: Company Snapshot
Table 19: Alnylam Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 20: Alnylam Pharmaceuticals Inc.: Product Portfolio
Table 21: Alnylam Pharmaceuticals Inc.: News/Key Developments, 2023 and 2024
Table 22: Amgen Inc.: Company Snapshot
Table 23: Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 24: Amgen Inc.: Product Portfolio
Table 25: Amgen Inc.: News/Key Developments, 2023-2025
Table 26: Argenx: Company Snapshot
Table 27: Argenx: Financial Performance, FY 2022 and 2023
Table 28: Argenx: Product Portfolio
Table 29: Argenx: News/Key Developments, 2023 and 2024
Table 30: Astellas Pharma Inc.: Company Snapshot
Table 31: Astellas Pharma Inc: Financial Performance, FY 2022 and 2023
Table 32: Astellas Pharma Inc.: Product Portfolio
Table 33: Astellas Pharma Inc.: News/Key Developments, 2023-2025
Table 34: AstraZeneca: Company Snapshot
Table 35: AstraZeneca: Financial Performance, FY 2022 and 2023
Table 36: AstraZeneca: Product Portfolio
Table 37: AstraZeneca: News/Recent Developments, 2023-2025
Table 38: Aurobindo Pharma Ltd.: Company Snapshot
Table 39: Aurobindo Pharma Ltd.: Financial Performance, FY 2022 and 2023
Table 40: Aurobindo Pharma Ltd.: Product Portfolio
Table 41: Aurobindo Pharma Ltd.: News/Key Developments, 2023 and 2024
Table 42: Bausch Health Companies Inc.: Company Snapshot
Table 43: Bausch Health Companies Inc.: Financial Performance, FY 2022 and 2023
Table 44: Bausch Health Companies Inc.: Product Portfolio
Table 45: Bausch Health Companies Inc.: News/Key Developments, 2023
Table 46: Baxter: Company Snapshot
Table 47: Baxter: Financial Performance, FY 2022 and 2023
Table 48: Baxter: Product Portfolio
Table 49: Baxter: News/Key Developments, 2023 and 2024
Table 50: Bayer AG: Company Snapshot
Table 51: Bayer AG: Financial Performance, FY 2022 and 2023
Table 52: Bayer AG: Product Portfolio
Table 53: Bayer AG: News/Key Developments, 2023-2025
Table 54: Biocon: Company Snapshot
Table 55: Biocon: Financial Performance, FY 2022 and 2023
Table 56: Biocon: Product Portfolio
Table 57: Biocon: News/Key Developments, 2023-2024
Table 58: Biogen: Company Snapshot
Table 59: Biogen: Financial Performance, FY 2022 and 2023
Table 60: Biogen: Product Portfolio
Table 61: Biogen: News/Key Developments, 2023-2025
Table 62: BioMarin: Company Snapshot
Table 63: BioMarin: Financial Performance, FY 2022 and 2023
Table 64: BioMarin: Product Portfolio
Table 65: BioMarin: News/Key Developments, 2021-2024
Table 66: BioNTech SE: Company Snapshot
Table 67: BioNTech SE: Financial Performance, FY 2022 and 2023
Table 68: BioNTech SE: Product Portfolio
Table 69: BioNTech: News/Key Developments, 2023-2025
Table 70: Boehringer Ingelheim International GmbH: Company Snapshot
Table 71: Boehringer Ingelheim International GmbH: Financial Performance, FY 2022 and 2023
Table 72: Boehringer Ingelheim International GmbH: Product Portfolio
Table 73: Boehringer Ingelheim International GmbH: News/Key Developments, 2023-2025
Table 74: Bristol-Myers Squibb Co.: Company Snapshot
Table 75: Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 76: Bristol-Myers Squibb Co.: Product Portfolio
Table 77: Bristol-Myers Squibb Co.: News/Key Developments, 2023 and 2024
Table 78: Chugai Pharmaceutical Co. Ltd.: Company Snapshot
Table 79: Chugai Pharmaceutical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 80: Chugai Pharmaceutical Co. Ltd.: Product Portfolio
Table 81: Chugai Pharmaceutical Co. Ltd: News/Key Developments, 2023-2025
Table 82: CSL: Company Snapshot
Table 83: CSL: Financial Performance, FY 2022 and 2023
Table 84: CSL: Product Portfolio
Table 85: CSL: News/Key Developments, 2023-2025
Table 86: CSPC Pharmaceutical Group Ltd.: Company Snapshot
Table 87: CSPC Pharmaceutical Group Ltd.: Financial Performance, FY 2022 and 2023
Table 88: CSPC Pharmaceutical Group Ltd.: Product Portfolio
Table 89: CSPC Pharmaceutical Group Ltd.: News/Key Developments, 2024
Table 90: Daiichi Sankyo Co. Ltd.: Company Snapshot
Table 91: Daiichi Sankyo Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 92: Daiichi Sankyo Co. Ltd.: Product Portfolio
Table 93: Daiichi Sankyo Co. Ltd.: News/Key Developments, 2022-2025
Table 94: Divi's Laboratories Ltd.: Company Snapshot
Table 95: Divi's Laboratories Ltd.: Financial Performance, FY 2022 and 2023
Table 96: Divi's Laboratories Ltd.: Product Portfolio
Table 97: Eisai Co. Ltd.: Company Snapshot
Table 98: Eisai Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 99: Eisai Co. Ltd.: Product Portfolio
Table 100: Eisai Co. Ltd.: News/Recent Developments, 2023-2025
Table 101: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 102: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 103: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 104: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023-2025
Table 105: Galderma: Company Snapshot
Table 106: Galderma: Financial Performance, FY 2022 and 2023
Table 107: Galderma: Product Portfolio
Table 108: Galderma: News/Key Developments, 2024
Table 109: Gilead Sciences Inc.: Company Snapshot
Table 110: Gilead Sciences Inc.: Financial Performance, FY 2022 and 2023
Table 111: Gilead Sciences Inc.: Product Portfolio
Table 112: Gilead Sciences Inc.: News/Key Developments, 2023-2025
Table 113: Grifols S.A: Company Snapshot
Table 114: Grifols S.A.: Financial Performance, FY 2022 and 2023
Table 115: Grifols S.A: Product Portfolio
Table 116: Grifols S.A: News/Key Developments, 2023-2025
Table 117: GSK plc.: Company Snapshot
Table 118: GSK plc.: Financial Performance, FY 2022 and 2023
Table 119: GSK plc.: Product Portfolio
Table 120: GSK plc.: News/Key Developments, 2023-2025
Table 121: H. Lundbeck A/S: Company Snapshot
Table 122: H. Lundbeck A/S: Financial Performance, FY 2022 and 2023
Table 123: H. Lundbeck A/S: Product Portfolio
Table 124: H. Lundbeck A/S: News/Key Developments, 2022-2024
Table 125: Incyte: Company Snapshot
Table 126: Incyte: Financial Performance, FY 2022 and 2023
Table 127: Incyte: Product Portfolio
Table 128: Incyte: News/Key Developments, 2023-2025
Table 129: Jazz Pharmaceuticals Inc.: Company Snapshot
Table 130: Jazz Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 131: Jazz Pharmaceuticals Inc.: Product Portfolio
Table 132: Jazz Pharmaceuticals Inc.: News/Key Developments, 2023 and 2024
Table 133: Johnson & Johnson Services Inc.: Company Snapshot
Table 134: Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 135: Johnson & Johnson Services Inc.: Product Portfolio
Table 136: Johnson & Johnson Services Inc.: News/Key Developments, 2022-2024
Table 137: Les Laboratoires Servier: Company Snapshot
Table 138: Les Laboratoires Servier: Financial Performance, FY 2022 and 2023
Table 139: Les Laboratoires Servier: Product Portfolio
Table 140: Les Laboratoires Servier: News/Key Developments, 2023-2025
Table 141: Lilly: Company Snapshot
Table 142: Lilly: Financial Performance, FY 2022 and 2023
Table 143: Lilly: Product Portfolio
Table 144: Lilly: News/Key Developments, 2022-2025
Table 145: Merck & Co. Inc.: Company Snapshot
Table 146: Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
Table 147: Merck & Co. Inc.: Product Portfolio
Table 148: Merck & Co. Inc.: News/Key Developments, 2021-2024
Table 149: Merck KGaA: Company Snapshot
Table 150: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 151: Merck KGaA: Product Portfolio
Table 152: Merck KGaA: News/Key Developments, 2023-2025
Table 153: Moderna Inc.: Company Snapshot
Table 154: Moderna Inc.: Financial Performance, FY 2022 and 2023
Table 155: Moderna Inc.: Product Portfolio
Table 156: Moderna Inc.: News/Key Developments, 2023 and 2024
Table 157: Neurocrine Biosciences Inc: Company Snapshot
Table 158: Neurocrine Biosciences Inc: Financial Performance, FY 2022 and 2023
Table 159: Neurocrine Biosciences Inc: Product Portfolio
Table 160: Neurocrine Biosciences Inc: News/Key Developments, 2023-2025
Table 161: Novartis AG: Company Snapshot
Table 162: Novartis AG: Financial Performance, FY 2022 and 2023
Table 163: Novartis AG: Product Portfolio
Table 164: Novartis AG: News/Key Developments, 2022-2024
Table 165: Novo Nordisk A/S: Company Snapshot
Table 166: Novo Nordisk A/S: Financial Performance, FY 2022 and 2023
Table 167: Novo Nordisk A/S: Product Portfolio
Table 168: Novo Nordisk A/S: News/Key Developments, 2023-2025
Table 169: Otsuka Holdings Co. Ltd.: Company Snapshot
Table 170: Otsuka Holdings Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 171: Otsuka Holdings Co. Ltd.: Product Portfolio
Table 172: Otsuka Holdings Co. Ltd.: News/Key Developments, 2023 and 2024
Table 173: Pfizer Inc.: Company Snapshot
Table 174: Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 175: Pfizer Inc.: Product Portfolio
Table 176: Pfizer Inc.: News/Key Developments, 2023 and 2024
Table 177: Regeneron Pharmaceuticals Inc.: Company Snapshot
Table 178: Regeneron Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 179: Regeneron Pharmaceuticals Inc.: Product Portfolio
Table 180: Regeneron Pharmaceuticals Inc.: News/Key Developments, 2022-2024
Table 181: Sanofi: Company Snapshot
Table 182: Sanofi: Financial Performance, FY 2022 and 2023
Table 183: Sanofi: Product Portfolio
Table 184: Sanofi: News/Key Developments, 2022-2025
Table 185: Sino Biopharmaceutical Co. Ltd.: Company Snapshot
Table 186: Sino Biopharmaceutical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 187: Sino Biopharmaceutical Co. Ltd.: Product Portfolio
Table 188: Sino Biopharmaceutical Co. Ltd.: News/Key Developments, 2023-2025
Table 189: Sun Pharmaceutical Industries Ltd.: Company Snapshot
Table 190: Sun Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 191: Sun Pharmaceutical Industries Ltd.: Product Portfolio
Table 192: Sun Pharmaceutical Industries Ltd.: News/Key Developments, 2022-2024
Table 193: Takeda Pharmaceutical Co. Ltd.: Company Snapshot
Table 194: Takeda Pharmaceutical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 195: Takeda Pharmaceutical Co. Ltd.: Product Portfolio
Table 196: Takeda Pharmaceutical Co. Ltd.: News/Key Developments, 2023 and 2024
Table 197: Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 198: Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 199: Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 200: Vertex Pharmaceuticals Inc.: Company Snapshot
Table 201: Vertex Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 202: Vertex Pharmaceuticals Inc.: Product Portfolio
Table 203: Vertex Pharmaceuticals Inc.: News/Key Developments, 2022-2025
Table 204: Viatris Inc.: Company Snapshot
Table 205: Viatris Inc.: Financial Performance, FY 2022 and 2023
Table 206: Viatris Inc.: Product Portfolio
Table 207: Viatris Inc.: News/Key Developments, 2023 and 2024
Table 208: Few Emerging Players in the Market
List of Figures
Summary Figure: Global Market Shares of Pharmaceutical Drugs, by Region, 2023
Figure 1: Supply Chain of the Pharmaceutical Drugs Industry
Figure 2: Pharmaceutical Drug Industry Market Dynamics
Figure 3: Trends and Emerging Technologies in the Pharmaceutical Drug Industry
Figure 4: Global Market Shares of Leading Pharmaceutical Drug Companies, 2023
Figure 5: Abbott: Revenue Share, by Business Unit, FY 2023
Figure 6: Abbott: Revenue Share, by Country/Region, FY 2023
Figure 7: AbbVie Inc.: Revenue Share, by Business Unit, FY 2023
Figure 8: AbbVie Inc.: Revenue Share, by Country/Region, FY 2023
Figure 9: Alnylam Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 10: Alnylam Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 11: Amgen Inc.: Revenue Share, by Business Unit, FY 2023
Figure 12: Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 13: Argenx: Revenue Share, by Country/Region, FY 2023
Figure 14: Astellas Pharma Inc.: Revenue Share, by Business Unit, FY 2023
Figure 15: Astellas Pharma Inc.: Revenue Share, by Country/Region, FY 2023
Figure 16: AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 17: AstraZeneca: Revenue Share, by Region/Country, FY 2023
Figure 18: Aurobindo Pharma Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 19: Aurobindo Pharma Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 20: Bausch Health Companies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 21: Bausch Health Companies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 22: Baxter: Revenue Share, by Business Unit, FY 2023
Figure 23: Baxter: Revenue Share, by Country/Region, FY 2023
Figure 24: Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 25: Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 26: Biocon: Revenue Share, by Business Unit, FY 2023
Figure 27: Biogen: Revenue Share, by Business Unit, FY 2023
Figure 28: Biogen: Revenue Share, by Country/Region, FY 2023
Figure 29: BioMarin: Revenue Share, by Business Unit, FY 2023
Figure 30: BioMarin: Revenue Share, by Country/Region, FY 2023
Figure 31: BioNTech SE: Revenue Share, by Business Unit, FY 2023
Figure 32: Boehringer Ingelheim International GmbH: Revenue Share, by Business Unit, FY 2023
Figure 33: Boehringer Ingelheim International GmbH: Revenue Share, by Region/Country, FY 2023
Figure 34: Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 35: Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 36: Chugai Pharmaceutical Co. Ltd.: Revenue Share, by Region, FY 2023
Figure 37: CSL: Revenue Share, by Business Unit, FY 2023
Figure 38: CSL: Revenue Share, by Region, FY 2023
Figure 39: CSPC Pharmaceutical Group Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 40: CSPC Pharmaceutical Group Ltd.: Revenue Share, by Region, FY 2023
Figure 41: Daiichi Sankyo Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42: Daiichi Sankyo Co. Ltd.: Revenue Share, by Region, FY 2023
Figure 43: Divi's Laboratories Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 44: Eisai Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 45: Eisai Co. Ltd.: Revenue Share, by Region/Country, FY 2023
Figure 46: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 47: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 48: Galderma: Revenue Share, by Business Unit, FY 2023
Figure 49: Galderma: Revenue Share, by Country/Region, FY 2023
Figure 50: Gilead Sciences Inc.: Revenue Share, by Business Unit, FY 2023
Figure 51: Gilead Sciences Inc.: Revenue Share, by Country/Region, FY 2023
Figure 52: Grifols S.A: Revenue Share, by Business Unit, FY 2023
Figure 53: Grifols S.A.: Revenue Share, by Region, FY 2023
Figure 54: GSK plc.: Revenue Share, by Business Unit, FY 2023
Figure 55: GSK plc.: Revenue Share, by Country/Region, FY 2023
Figure 56: H. Lundbeck A/S: Revenue Share, by Business Unit, FY 2023
Figure 57: H. Lundbeck A/S: Revenue Share, by Country/Region, FY 2023
Figure 58: Incyte: Revenue Share, by Business Unit, FY 2023
Figure 59: Jazz Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 60: Jazz Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 61: Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 62: Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 63: Les Laboratoires Servier: Revenue Share, by Business Unit, FY 2023
Figure 64: Les Laboratoires Servier: Revenue Share, by Region, FY 2023
Figure 65: Lilly: Revenue Share, by Business Unit, FY 2023
Figure 66: Lilly: Revenue Share, by Country/Region, FY 2023
Figure 67: Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2023
Figure 68: Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2023
Figure 69: Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 70: Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 71: Moderna Inc.: Revenue Share, by Country/Region, FY 2023
Figure 72: Neurocrine Biosciences Inc: Revenue Share, by Business Unit, FY 2023
Figure 73: Novartis AG: Revenue Share, by Business Unit, FY 2023
Figure 74: Novartis AG: Revenue Share, by Country/Region, FY 2023
Figure 75: Novo Nordisk A/S: Revenue Share, by Business Unit, FY 2023
Figure 76: Novo Nordisk A/S: Revenue Share, by Country/Region, FY 2023
Figure 77: Otsuka Holdings Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 78: Otsuka Holdings Co. Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 79: Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
Figure 80: Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 81: Regeneron Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 82: Regeneron Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 83: Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 84: Sanofi: Revenue Share, by Country/Region, FY 2023
Figure 85: Sino Biopharmaceutical Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 86: Sino Biopharmaceutical Co. Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 87: Sun Pharmaceutical Industries Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 88: Takeda Pharmaceutical Co. Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 89: Takeda Pharmaceutical Co. Ltd.: Revenue Share, by Region, FY 2023
Figure 90: Teva Pharmaceutical Industries Ltd: Revenue Share, by Business Unit, FY 2023
Figure 91: Teva Pharmaceutical Industries Ltd: Revenue Share, by Country/Region, FY 2023
Figure 92: Vertex Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 93: Vertex Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 94: Viatris Inc.: Revenue Share, by Business Unit, FY 2023
Figure 95: Viatris Inc.: Revenue Share, by Country/Region, FY 2023
